NEW YORK, July 12 (GenomeWeb News) - CombiMatrix Molecular Diagnostics, a newly created subsidiary of CombiMatrix, has begun negotiating with undisclosed potential distributors and customers, the company said today.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
